现货大促销,价格低至8折起,量大更优惠,详细咨询客服
全部分类
全部分类
  • Tandutinib (MLN518)
Tandutinib (MLN518)的可视化放大

Tandutinib (MLN518)

An antagonist of PDGFRβ, FLT3, and c-Kit

原价
¥662-2200
价格
530-1760
Tandutinib (MLN518)的二维码

所有产品仅用于科学研究,我们不为任何个人用途提供产品和服务

询价有惊喜,量大更优惠 点击这里给我发消息

  • 库存: 现货
可选包装 >>>
首页
  • 货号: ajci14750
  • CAS: 387867-13-2
  • 别名: 坦度替尼; MLN518; CT53518
  • 分子式: C31H42N6O4
  • 分子量: 562.72
  • 纯度: >98%
  • 溶解度: ≥ 17.85mg/mL in DMSO
  • 储存: Store at -20°C
  • 库存: 现货

Background

Tandutinib (MLN518, CT53518) is a novel, selective and small-molecule inhibitor of FLT3 with IC50 value of 0.22μM [1].


Tandutinib (MLN518) has been reported to inhibit FLT3, PDGFR and c-Kit in in vitro kinase assays with IC50 values of 0.22μM, 0.20μM and 0.17μM, respectively. In addition, Tandutinib (MLN518) has been revealed to inhibit wild-type FLT3 or W51 tyrosine phosphorylation with an IC50 value of 30–100 nM. Furthermore, Tandutinib (MLN518) has shown the cell antiproliferation of the FLT3-ITD-positive cells (Molm-13 and Molm-14 cells) with an IC50 value of 10 nM, whereas the FLT3-ITD-negative cells ( THP-1, KG-1, and RS4 cells) were resistant, requiring 1000-fold higher concentrations to inhibit cell growth [1]

参考文献:
[1] Kelly LM1, Yu JC, Boulton CL, Apatira M, Li J, Sullivan CM, Williams I, Amaral SM, Curley DP, Duclos N, Neuberg D, Scarborough RM, Pandey A, Hollenbach S, Abe K, Lokker NA, Gilliland DG, Giese NA. CT53518, a novel selective FLT3 antagonist for the treatment of acute myelogenous leukemia (AML). Cancer Cell. 2002 Jun;1(5):421-32.

动态评分

0.0

没有评分数据
没有评价数据
一键回到顶部
展开 收缩
安捷凯在线客服